Gene · 57167
Papers3,058
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,058
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Case report: Primary pulmonary rhabdomyosarcoma exhibiting epithelial morphology and unusual immunophenotype - A significant diagnostic pitfall. | Respir Med Case Rep | 2026 | 41783407 | PubTator, text mining | PubMed |
| Primary prostatic yolk sac tumor: A rare case report and literature review. | Urol Case Rep | 2026 | 41768349 | PubTator, text mining | PubMed |
| Unusual immunohistochemical profiles in hemangioblastomas and their relevance in differential diagnosis: A comprehensive study of 112 cases. | J Neuropathol Exp Neurol | 2026 | 41762700 | PubTator, text mining | PubMed |
| Bilateral extramidline involvement in intracranial germinoma: diagnostic lessons from a complex presentation. | Arq Neuropsiquiatr | 2026 | 41760094 | PubTator, text mining | PubMed |
| Targeting mutant VHL-gene results in therapy response in metastatic clear cell carcinoma of rete testis. | Urol Case Rep | 2026 | 41756742 | PubTator, text mining | PubMed |
| Integrated Prenatal Genetic Evaluation of Renal Agenesis: Chromosomal Microarray Analysis, Whole Exome Sequencing, and Outcome Correlations in 203 Fetuses. | Genes (Basel) | 2026 | 41751559 | PubTator, text mining | PubMed |
| Penile metastasis from prostate cancer with CDK12 mutation: A case report and literature review. | Oncol Lett | 2026 | 41743014 | PubTator, text mining | PubMed |
4-(5-Chloro-3-(3,4,5-trimethoxybenzoyl)-1H-indol-1-yl)benzenesulfonamide: A Novel Polypharmacology Agent to Target Carbonic Anhydrase IX and XII With Improved Selectivity, Wnt/β-Catenin Signaling Pathway, and P-Glycoprotein. | ChemMedChem | 2026 | 41739665 | PubTator, text mining | PubMed |
| International guidelines on the diagnosis and treatment of NUT carcinoma. | Innovation (Camb) | 2026 | 41737331 | PubTator, text mining | PubMed |
| A Case of Prostatic Mixed Germ Cell Tumor Showing Pagetoid Spread Into the Vas Deference in a Patient With Klinefelter Syndrome. | Pathol Int | 2026 | 41736172 | PubTator, text mining | PubMed |
| A gastric and pleural metastasis of occult breast lobular cancer in an elderly female and radiomics assisted analysis of a rare metastasis. | Front Oncol | 2026 | 41727659 | PubTator, text mining | PubMed |
| Mullerian-Type Clear Cell Carcinoma in Late Metastasis of Testicular Teratoma: First Report of a Unique Association. | Int J Surg Pathol | 2026 | 41724498 | PubTator, text mining | PubMed |
| Practical marker-based stratification of early gastric neoplasms in older adults. | Am J Clin Pathol | 2026 | 41711636 | PubTator, text mining | PubMed |
| Discovery of BMS-986458, a Potent and Selective B-Cell Lymphoma 6 Protein Ligand-Directed Degrader, for the Treatment of B-Cell Non-Hodgkin Lymphoma. | J Med Chem | 2026 | 41670385 | PubTator, text mining | PubMed |
| The Relationship between SALL4 and Fascin Expression and the Progression of Colorectal Carcinoma. | Asian Pac J Cancer Prev | 2026 | 41660921 | PubTator, text mining | PubMed |
| Integrating multi-omics analysis identifies DNA damage-related gene CLSPN as a biomarker in gastric cancer. | Sci Rep | 2026 | 41656416 | PubTator, text mining | PubMed |
| The Oncogenic Role of Serum Marker GDF15 in Promoting Colorectal Tumorigenesis via EMT and Stemness. | Stem Cells Int | 2026 | 41648863 | PubTator, text mining | PubMed |
| T Cell Exhaustion in Hepatocellular Carcinoma: A Substantial Barrier in Immunotherapy. | J Cell Mol Med | 2026 | 41645702 | PubTator, text mining | PubMed |
| Endometrial Carcinoma of Gastrointestinal-type (EMCG): Incidence, Molecular Features, and Distinction From Other Endometrial Cancers With Gastrointestinal Marker Immunoexpression. | Int J Gynecol Pathol | 2026 | 41642929 | PubTator, text mining | PubMed |
| Primary uterine yolk sac tumour: a rare and aggressive malignancy - navigating diagnostic uncertainty and treatment pathway. | BMJ Case Rep | 2026 | 41638763 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57167/papers?page=4